IBO insider transactions
Impact BioMedical Inc. (IBO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
IBO insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Impact BioMedical Inc., latest first. Follow anyone to get their next filing.
- Mark SuseckChief Operating Officer, since September 2024
- Christian Thomas ZimmermanDirector, since September 2024
- Castel Berisford HibbertDirector, since September 2024
- Melissa Kaye SimsDirector, since September 2024
- David K KeeneDirector, since September 2024
- Elise BrownellDirector, since September 2024
- Chan Heng Fai AmbroseDirector, 10% owner, since September 2024-$4.21M
- Jason GradyDirector, since September 2024-$32.5K
- Todd D MackoChief Financial Officer, since September 2024-$25.3K
- Dss, Inc.10% owner, since September 2024+$156K-$3.24M
- Frank D HeuszelChief Executive Officer, Director, since September 2024+$5,173
Recent Form 3, 4, and 5 filings for IBO
- Chief Operating Officer Suseck Mark gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Zimmerman Christian Thomas gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Hibbert Castel Berisford gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Sims Melissa Kaye gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Keene David K gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Brownell Elise gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Chan Heng Fai Ambrose gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Grady Jason gave a grant of 4,170 shares, decreasing direct ownership by 13% to 28,164 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Chief Financial Officer Macko Todd D gave a grant of 4,170 shares, decreasing direct ownership by 20% to 16,462 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. sold $1,686 worth of shares (906 units at $1.86), decreasing direct ownership by 0.15% to 589,518 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 4 filed by Macko Todd D4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 4 filed by Grady Jason4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. sold $88,006 worth of shares (161,000 units at $0.55), decreasing direct ownership by 23% to 545,024 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. sold $845,013 worth of shares (890,800 units at $0.95), decreasing direct ownership by 85% to 161,100 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Chan Heng Fai Ambrose sold $174,020 worth of shares (351,555 units at $0.49) (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Chan Heng Fai Ambrose sold $1,122,920 worth of shares (1,689,693 units at $0.66) (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Director Chan Heng Fai Ambrose sold $392,800 worth of shares (400,000 units at $0.98) and sold $2,520,021 worth of shares (2,126,918 units at $1.18) (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. sold $1,950,928 worth of shares (605,620 units at $3.22), decreasing direct ownership by 9% to 1,051,800 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. sold $249,408 worth of shares (53,300 units at $4.68) and bought $310 worth of shares (200 units at $1.55) (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Chief Executive Officer Heuszel Frank D bought $1,129 worth of shares (500 units at $2.26), increasing direct ownership by 0.52% to 97,344 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Chief Executive Officer Heuszel Frank D bought $1,305 worth of shares (500 units at $2.61), increasing direct ownership by 0.52% to 96,844 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Chief Executive Officer Heuszel Frank D bought $2,739 worth of shares (1,050 units at $2.61), increasing direct ownership by 1% to 96,344 units (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. sold $17,024 worth of shares (5,700 units at $2.99) (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. bought $2,330 worth of shares (1,000 units at $2.33) (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Large owner Dss, Inc. bought $153,220 worth of shares (57,800 units at $2.65) (SEC Form 4)4 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- Amendment: New insider Dss, Inc. claimed ownership of 1,678,682 shares (SEC Form 3)3/A - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- New insider Dss, Inc. claimed ownership of 1,678,682 shares (SEC Form 3)3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 3 filed by new insider Sims Melissa Kaye3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 3 filed by new insider Brownell Elise3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- New insider Grady Jason claimed ownership of 182 shares (SEC Form 3)3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- New insider Chan Heng Fai Ambrose claimed ownership of 4,568,165 shares (SEC Form 3)3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- New insider Macko Todd D claimed ownership of 121 shares (SEC Form 3)3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 3 filed by new insider Zimmerman Christian Thomas3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 3 filed by new insider Hibbert Castel Berisford3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- New insider Heuszel Frank D claimed ownership of 95,475 shares (SEC Form 3)3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 3 filed by new insider Keene David K3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)
- SEC Form 3 filed by new insider Suseck Mark3 - IMPACT BIOMEDICAL INC. (0001834105) (Issuer)